Sign in or create an account to add this stock to your watchlist.
About Core Laboratories (NYSE:CLB)
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Industry, Sector and Symbol
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
SymbolNYSE:CLB
CUSIPN/A
Phone31-20-420-3191
Debt
Debt-to-Equity Ratio1.55
Current Ratio2.11
Quick Ratio1.76
Price-To-Earnings
Trailing P/E Ratio61.15
Forward P/E Ratio45.13
P/E GrowthN/A
Sales & Book Value
Annual Sales$659.81 million
Price / Sales8.19
Cash Flow$2.5664 per share
Price / Cash47.65
Book Value$3.43 per share
Price / Book35.65
Profitability
EPS (Most Recent Fiscal Year)$2.00
Net Income$83.12 million
Net Margins13.24%
Return on Equity62.69%
Return on Assets16.15%
Miscellaneous
Employees4,600
Outstanding Shares44,200,000
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories announced a quarterly dividend on Tuesday, April 17th. Shareholders of record on Friday, April 27th will be paid a dividend of $0.55 per share on Tuesday, May 22nd. This represents a $2.20 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend is Thursday, April 26th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) announced its quarterly earnings data on Wednesday, April, 25th. The oil and gas company reported $0.57 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.57. The oil and gas company earned $170 million during the quarter, compared to analysts' expectations of $171.03 million. Core Laboratories had a return on equity of 62.69% and a net margin of 13.24%. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.42 EPS. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.66. The company issued revenue guidance of $177-179 million, compared to the consensus revenue estimate of $178.11 million.
What price target have analysts set for CLB?
11 brokers have issued 12-month price objectives for Core Laboratories' stock. Their forecasts range from $96.00 to $136.00. On average, they expect Core Laboratories' share price to reach $113.4940 in the next year. View Analyst Ratings for Core Laboratories.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), Oceaneering International (OII), FTS International (FTSI), SemGroup Energy Partners (SEMG), C&J Energy Services (CJ), Superior Energy Services (SPN), Keane Group (FRAC), Frank's International (FI), Select Energy Services (WTTR), Mammoth Energy Services (TUSK), Helix Energy Solutions Group (HLX), Hurricane Energy (HRCXF) and NCS Multistage (NCSM).
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, Chairman of Supervisory Board, CEO & Pres (Age 63)
- Mr. Richard L. Bergmark, Chief Financial Officer, Exec. VP and Supervisory Director (Age 65)
- Mr. Monty L. Davis, Chief Operating Officer and Sr. VP (Age 64)
- Mr. Lawrence V. Bruno, Pres (Age 58)
- Mr. Christopher Scott Hill, Sr. VP & Chief Accounting Officer (Age 48)
Has Core Laboratories been receiving favorable news coverage?
News articles about CLB stock have trended positive on Sunday, Accern Sentiment reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Core Laboratories earned a media sentiment score of 0.42 on Accern's scale. They also assigned news stories about the oil and gas company an impact score of 46.47 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by many different of retail and institutional investors. Top institutional investors include WCM Investment Management CA (11.39%), BlackRock Inc. (6.94%), Kayne Anderson Rudnick Investment Management LLC (4.92%), Earnest Partners LLC (4.41%), Massachusetts Financial Services Co. MA (4.04%) and Epoch Investment Partners Inc. (2.72%). Company insiders that own Core Laboratories stock include Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.
Which institutional investors are selling Core Laboratories stock?
CLB stock was sold by a variety of institutional investors in the last quarter, including Sustainable Growth Advisers LP, Russell Investments Group Ltd., Millennium Management LLC, Legal & General Group Plc, Envestnet Asset Management Inc., Oppenheimer & Co. Inc., Franklin Resources Inc. and Brinker Capital Inc.. View Insider Buying and Selling for Core Laboratories.
Which institutional investors are buying Core Laboratories stock?
CLB stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Massachusetts Financial Services Co. MA, WCM Investment Management CA, Sei Investments Co., Arosa Capital Management LP, BlackRock Inc., Kayne Anderson Rudnick Investment Management LLC and Epoch Investment Partners Inc.. Company insiders that have bought Core Laboratories stock in the last two years include Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $122.29.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $5.41 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
Core Laboratories (NYSE:CLB) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for Core Laboratories in the last 12 months. Their average twelve-month price target is $113.4940, suggesting that the stock has a possible downside of 7.19%. The high price target for CLB is $136.00 and the low price target for CLB is $96.00. There are currently 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.36 | 2.36 | 2.33 | 2.36 |
| Ratings Breakdown: | 0 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
8 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
7 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $113.4940 | $111.1940 | $111.70 | $108.6364 |
| Price Target Upside: | 7.19% downside | 4.95% downside | 4.12% downside | 15.79% upside |
Core Laboratories (NYSE:CLB) Consensus Price Target History
Core Laboratories (NYSE:CLB) Analyst Ratings History
Show:
(Data available from 5/27/2016 forward)
Core Laboratories (NYSE:CLB) Dividend Information
Core Laboratories pays an annual dividend of $2.20 per share, with a dividend yield of 1.80%. CLB's most recent quarterly dividend payment was Tuesday, May 22. Core Laboratories pays out 110.00% of its earnings out as a dividend.
| Most Recent Dividend: | 5/22/2018 |
| Annual Dividend: | $2.20 |
| Dividend Yield: | 1.80% |
| Dividend Growth: | 3.20% (3 Year Average) |
| Payout Ratio(s): | 110.00% (Trailing 12 Months of Earnings)
81.18% (Based on This Year's Estimates)
65.09% (Based on Next Year's Estimates)
85.72% (Based on Cash Flow)
|
| Frequency: | Quarterly Dividend |
Core Laboratories (NYSE:CLB) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/17/2018 | Quarterly | $0.55 | 1.8% | 4/26/2018 | 4/27/2018 | 5/22/2018 |
| 1/16/2018 | Quarterly | $0.55 | 2.03% | 1/25/2018 | 1/26/2018 | 2/16/2018 |
| 10/10/2017 | quarterly | $0.55 | | 10/19/2017 | 10/20/2017 | 11/21/2017 |
| 7/6/2017 | Quarterly | $0.55 | 2.11% | 7/13/2017 | 7/17/2017 | 8/14/2017 |
| 4/19/2017 | quarterly | $0.55 | 1.98% | 4/27/2017 | 4/28/2017 | 5/23/2017 |
| 1/10/2017 | Quarterly | $0.55 | 1.8% | 1/18/2017 | 1/20/2017 | 2/17/2017 |
| 10/11/2016 | Quarterly | $0.55 | 1.95% | 10/19/2016 | 10/21/2016 | 11/22/2016 |
| 7/7/2016 | Quarterly | $0.55 | | 7/14/2016 | 7/18/2016 | 8/15/2016 |
| 4/15/2016 | Quarterly | $0.55 | | 5/2/2016 | 5/4/2016 | 5/24/2016 |
| 1/11/2016 | Quarterly | $0.55 | 2.28% | 1/20/2016 | 1/22/2016 | 2/19/2016 |
| 10/13/2015 | Quarterly | $0.55 | | 10/21/2015 | 10/23/2015 | 11/24/2015 |
| 7/7/2015 | quarterly | $0.55 | 2.02% | 7/15/2015 | 7/17/2015 | 8/17/2015 |
| 1/12/2015 | | $0.55 | | 1/21/2015 | 1/23/2015 | 2/20/2015 |
| 10/6/2014 | quarterly | $0.50 | 1.39% | 10/16/2014 | 10/17/2014 | 11/25/2014 |
| 7/8/2014 | quarterly | $0.50 | | 7/16/2014 | 7/18/2014 | 8/18/2014 |
| 4/14/2014 | quarterly | $0.50 | 1.33% | 4/23/2014 | 4/25/2014 | 5/23/2014 |
| 1/13/2014 | quarterly | $0.50 | 1.05% | 1/22/2014 | 1/24/2014 | 2/21/2014 |
| 10/8/2013 | quarterly | $0.32 | 0.73% | 10/16/2013 | 10/18/2013 | 11/20/2013 |
| 7/9/2013 | quarterly | $0.32 | 0.82% | 7/17/2013 | 7/19/2013 | 8/19/2013 |
| 4/15/2013 | quarterly | $0.32 | 1.01% | 4/24/2013 | 4/26/2013 | 5/24/2013 |
| 1/11/2013 | quarterly | $0.32 | | | 1/22/2013 | 2/22/2013 |
(Data available from 1/1/2013 forward)
Core Laboratories (NYSE CLB) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.00%
Core Laboratories (NYSE CLB) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/1/2017 | Michael Straughen | Director | Buy | 106 | $118.65 | $12,576.90 | 106 |  |
| 1/30/2017 | Martha Z Carnes | Director | Buy | 200 | $115.20 | $23,040.00 | 200 | |
| 2/2/2016 | Jan Willem Sodderland | Director | Buy | 300 | $93.90 | $28,170.00 | 2,452 | |
| 5/12/2015 | Michael C Kearney | Director | Sell | 1,000 | $128.52 | $128,520.00 | | |
| 11/17/2014 | Mark F Elvig | VP | Sell | 1,000 | $138.03 | $138,030.00 | | |
| 7/28/2014 | Richard L Bergmark | CFO | Buy | 7,000 | $147.31 | $1,031,170.00 | | |
| 3/7/2014 | Michael Kearney | Director | Sell | 2,000 | $193.00 | $386,000.00 | 10,361 | |
| 2/14/2014 | Mark Elvig | VP | Sell | 1,500 | $186.64 | $279,960.00 | 15,784 | |
| 10/21/2013 | Monty L Davis | COO | Sell | 5,704 | $197.33 | $1,125,570.32 | | |
| 8/7/2013 | Richard Bergmark | CFO | Sell | 20,000 | $149.58 | $2,991,600.00 | 38,853 | |
| 7/25/2013 | Charles Brigham Miller | CAO | Sell | 11,648 | $147.81 | $1,721,690.88 | | |
| 7/25/2013 | Monty L Davis | COO | Sell | 5,948 | $149.12 | $886,965.76 | | |
(Data available from 1/1/2013 forward)
Core Laboratories (NYSE CLB) News Headlines
| Source: |
|
Core Laboratories (NYSE:CLB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Core Laboratories (NYSE:CLB) Income Statement, Balance Sheet and Cash Flow Statement
Core Laboratories (NYSE CLB) Stock Chart for Sunday, May, 27, 2018
Loading chart…
